Biotech China 2014
9th Investigator Initiated Trials
InterContinental Miami
100 CHOPIN PLAZA
Miami, FL
http://www.exlpharma.com/eventAgenda.php?id=156

Schedule of Presentations:

Friday, February 6, 2009
08:00:00 CONTINENTAL BREAKFAST & CONFERENCE REGISTRATION
09:00:00 PRE-CONFERENCE WORKSHOP : Managing Legal Issues in Investigator- Initiated Trials (IITs) including Clinical Trial Agreements Kristian Werling, Frederick M Frankhauser
10:30:00 30-MINUTE NETWORKING AND REFRESHMENT BREAK
12:00:00 Workshop Concludes; Luncheon for Workshop Participants
13:10:00 CONFERENCE OPENS : Chairperson's Opening Remarks Daniel Pardi
13:15:00 KEYNOTE PRESENTATION : Lessons from the FREEDOM Trial: A Large International Multi-center Multidisciplinary IIT Michael Farkouh
14:15:00 TACKLING SAFETY REPORTING ISSUES : Serious Adverse Event Reporting for IITs Mary Ruth Voehl
15:15:00 30-MINUTE NETWORKING AND REFRESHMENT BREAK
15:45:00 IISRA WORKING GROUP Stephen Shinall, Daniel Pardi, Leonard Humel, Karen Bartels
17:15:00 DAY ONE CONCLUDES
Saturday, February 7, 2009
08:50:00 Chairperson's Recap of Day One Daniel Pardi
09:00:00 DAY ONE RE-CAP : IISRA Follow-up and Re-Cap from Day One Daniel Pardi
09:30:00 NEW PHARMA CASE STUDY : Case Study: IIT Document Management Susan Watson
10:30:00 NETWORKING AND REFRESHMENT BREAK
11:00:00 MEDICAL DEVICE CASE STUDY : Medtronic Case Study: IITs in the Medical Device World James A Coles Jr.
13:15:00 Addressing the Practicalities of FMV in IIT Funding Decisions Anton Ehrhardt
14:00:00 NEW IIT TOPIC AREA : Unique challenges in data collection, analysis and reporting of IITs Jeffrey Zhang
14:00:00 NEW IIT TOPIC AREA : Difficulty in traditional supporting models Jeffrey Zhang
14:00:00 NEW IIT TOPIC AREA : Meeting Data Collection, Analysis and Reporting Challenges of IITs Jeffrey Zhang
15:15:00 CONFERENCE CONCLUDES; CHAIRPERSON'S CLOSING REMARKS
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.